Symic Bio, Inc.

Medtech

DS-SILY, a localized luminal vascular coating that binds to exposed collagen to prevent platelet adhesion and neointimal hyperplasia in hemodialysis arteriovenous fistulas

Grants
$200K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Exploring the Efficacy of a Proteoglycan Mimic for Treatment of Interstitial Cystitis$199,589
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1709ZENALUX BIOMEDICAL, INC.——
1710AIGENE, INC.——
1711NANOFIBER SOLUTIONS LLC——
1712Symic Bio, Inc.——
1713MaGPaD, LLC——
1714STERILE GEEKS VR INC——
1715TIOGA RESEARCH, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.